Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Main subject
Language
Document Type
Year range
1.
IEEE Access ; 2022.
Article in English | Scopus | ID: covidwho-1840229

ABSTRACT

The effectiveness of the first dose of vaccination for COVID-19 is different from that of the second dose;therefore, in several studies, various mathematical models that can represent the states of the first and second vaccination doses have been developed. Using the results of these studies and considering the effects of the first and second vaccination doses, we can simulate the spread of infectious diseases. The susceptible-infected-recovered-vaccination1-vaccination2-death (SIRVVD) model is one of the proposed mathematical models;however, it has not been sufficiently theoretically analyzed. Therefore, we obtained an analytical expression for the number of infected persons by considering the numbers of susceptible and vaccinated persons as parameters. We used the solution to determine the target vaccination rate for decreasing the infection numbers of the COVID-19 Delta variant (B.1.617) in Japan. Furthermore, we investigated the target vaccination rates for cases with strong or weak variants by comparing with the COVID-19 Delta variant (B.1.617). This study contributes to the mathematical development of the SIRVVD model and provides insights into the target vaccination rate for decreasing the number of infections. Author

2.
Math Biosci Eng ; 19(1): 1026-1040, 2022 01.
Article in English | MEDLINE | ID: covidwho-1560150

ABSTRACT

As of August 2021, COVID-19 is still spreading in Japan. Vaccination, one of the key measures to bring COVID-19 under control, began in February 2021. Previous studies have reported that COVID-19 vaccination reduces the number of infections and mortality rates. However, simulations of spreading infection have suggested that vaccination in Japan is insufficient. Therefore, we developed a susceptible-infected-recovered-vaccination1-vaccination2-death model to verify the effect of the first and second vaccination doses on reducing the number of infected individuals in Japan; this includes an infection simulation. The results confirm that appropriate vaccination measures will sufficiently reduce the number of infected individuals and reduce the mortality rate.


Subject(s)
COVID-19 , COVID-19 Vaccines , Humans , Japan , SARS-CoV-2 , Vaccination
SELECTION OF CITATIONS
SEARCH DETAIL